Phase 3 Choroidal Neovascularization Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 2Phase 3
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Age-Related Macular DegenerationMacular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd.960 enrolled20 locationsNCT07440225
Completed
Phase 3Phase 4
Intravitreal dexamethasone for resistant wet-AMD
Wet aged macular degenerationResistent choroidal neovascularization
A.O.U. Sassari20 enrolled1 locationACTRN12618001102268